| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.7 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |